http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2009000530-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
filingDate 2009-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e793206d1f5444fa926bd9d7558a52ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d96f9820da66cd86c4af944265e6f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c04b9af7ea01bfb307ec1cc649df1146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8d0834c8efcd0b639f345d7ecd0f32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e36338c07f6bbb3d32281d656197b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eaa9156b2ca958c3cec0009a373a6a2
publicationDate 2010-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2009000530-A1
titleOfInvention Compounds derived from amino-pyridin-3-yl-oxadiazole-phenyl, with agonist activity of the s1p1 / edg1 receptor; pharmaceutical composition; and the use of the compounds in the prevention or treatment of diseases related to the immune system, among others.
abstract Compounds derived from heterocycle substituted pyridine; pharmaceutical composition; and its use in disorders of the immune system, organ rejection, among other diseases.
priorityDate 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049

Total number of triples: 31.